VedaBio
Pre-clinicalUnlocking the true power of CRISPR for molecular detection. Our platform enables ultra-rapid molecular detection without the need for target amplification.
Founded
2021
Focus
Diagnostics
About
Unlocking the true power of CRISPR for molecular detection. Our platform enables ultra-rapid molecular detection without the need for target amplification.
Funding History
2Total raised: $60M
Series A$40MSection 32May 15, 2023
Seed$20MSection 32Jun 15, 2022
Company Info
TypePrivate
Founded2021
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile